Regulatory Track Record - India Sites

Ankleshwar & Mandva Facilities (Gujarat, India)

8 Global Regulatory Audits 100% Compliance History
Global Accreditations & Approvals
US FDAUS FDA
TGA AustraliaTGA Australia
MFDS KoreaMFDS Korea
WHO-GMPWHO-GMP

US FDA & MFDS inspection of the Ankleshwar facility

2013

US FDA inspection of the Mandva facility

2015

US FDA & Dept. of Health, Therapeutic Good Administration (TGA), Australia inspection of the Ankleshwar facility

2016

State FDA inspection of the Mandva facility

2020

CDSCO WHO-GMP inspection of the Ankleshwar & Mandva facilities

2021

State FDA inspection of the Ankleshwar facility

2022

US FDA inspection of the Ankleshwar facility

2023

US FDA inspection of the Mandva facility

2024

Regulatory Track Record - USA Site

Norac Pharma (Azusa, California, USA)

8 Regulatory Audits Schedule I–V DEA Licensed
Global Accreditations & Approvals
US FDAUS FDA
U.S. DEAU.S. DEA
CDPH CaliforniaCDPH California
WHO-GMPWHO-GMP

US FDA inspection of the Norac Site

2015

US FDA inspection of the Norac Site

2018

DEA Manufacturing license inspection of the Norac facility

2020

DEA Manufacturing license inspection of the Norac facility

2021

DEA Manufacturing license inspection of the Norac facility

2022

DEA Manufacturing license inspection of the Norac facility

2023

DEA Manufacturing license inspection of the Norac facility

2024

US FDA & DEA Manufacturing license inspection of the Norac facility

2025